Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Background/AimsAngiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are thought to reduce the dynamic portion of intrahepatic resistance. This study compared the effects of combined treatment using the ARB candesartan and propranolol versus propranolol monothe...

Full description

Bibliographic Details
Main Authors: Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2014-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Portal hypertension
Angiotensin receptor blocker
Non-selective beta blocker
Cirrhosis
Hepatic venous pressure gradient
Online Access:http://e-cmh.org/upload/pdf/cmh-20-376.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-20-376.pdf

Similar Items